Survival with distant metastatic disease in head and neck cancer : AA retrospective analysis;̈uberleben mit Ḧamatogen Metastasierten HNO-Tumoren : EEine Retrospektive Monozentrische Analyse

HNO

Volumn 55, Issue 10, 2007, Pages 785-791

  Dietl, B ^a   Marienhagen, J ^a   Schaefer, C ^a   Pohl, F ^a   Murthum, T ^b   Kolbl O ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Klinik und Poliklinik für Hals Nasen Ohren Heilkunde Universitätsklinikum Regensburg   (Germany)

Author keywords

Distant metastatic disease; ENT tumors; Local recurrence; Second primary; Survival

Indexed keywords

ARTICLE; FEMALE; GERMANY; HEAD AND NECK TUMOR; HUMAN; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; PALLIATIVE THERAPY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STATISTICS; SURVIVAL; SURVIVAL RATE;

FEMALE; GERMANY; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PALLIATIVE CARE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 35648947865     PISSN: 00176192     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00106-006-1522-4     Document Type: Article

References (42)

1. Adamo V, Ferraro G, Pergolizzi S et al. (2004) Paclitaxel and cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma. Oral Oncol 40: 525-531
2. Airoldi M, Cattel L, Marchionatti S et al. (2003) Docetaxel and vinorelbine in recurrent head and neck cancer: pharmacokinetic and clinical results. Am J Clin Oncol 26: 378-381
3. Arcangeli G, Giovinazzo G, Saracino B et al. (1998) Radiation therapy in the management of symptomatic bone metastases: the effect of total dose and histology on pain relief and response duration. Int J Radiat Oncol Biol Phys 42: 1119-1126
4. Ayache S, Peng J, Chatelain D et al. (2005) Therapeutic management of laryngeal cancer. Results of a study of 356 patients from the Cancer Registry of the Somme, France. Acta Otolaryngol 125: 1323-1326
5. Baumann I, Seibolt M, Zalaman I et al. (2006) Quality of life in patients with oropharyngeal carcinoma after primary surgery and postoperative irradiation. J Otolaryngol 35: 332-337
6. Baumann I, Seibolt M, Zalaman IM et al. (2006) Quality of life in patients with oropharyngeal carcinoma: Gender influences the subjective evaluation. HNO 54: 376-381
7. Bilde A, Von BC, Mortensen J et al. (2006) The role of SPECT-CT in the lymphoscintigraphic identification of sentinel nodes in patients with oral cancer. Acta Otolaryngol 126: 1096-1103
8. Buckley JG, Ferlito A, Shaha AR, Rinaldo A (2001) The treatment of distant metastases in head and neck cancer - present and future. ORL J Otorhinolaryngol Relat Spec 63: 259-264
9. Budach W, Hehr T, Budach V et al. (2006) A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck. BMC Cancer 6: 28
10. Calhoun KH, Fulmer P, Weiss R, Hokanson JA (1994) Distant metastases from head and neck squamous cell carcinomas. Laryngoscope 104: 1199-1205
11. Catimel G, Vermorken JB, Clavel M et al. (1994) A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group. Ann Oncol 5: 543-547
12. de Mulder PH (1999) The chemotherapy of head and neck cancer. Acta Otorhinolaryngol Belg 53: 247-252
13. Fanucchi M, Khuri FR (2004) Chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck. Semin Oncol 31: 809-815
14. Ferlito A, Shaha AR, Silver CE et al. (2001) Incidence and sites of distant metastases from head and neck cancer. ORL J Otorhinolaryngol Relat Spec 63: 202-207
15. Forastiere AA, Metch B, Schuller DE et al. (1992) Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study. J Clin Oncol 10: 1245-1251
16. Gebbia V, Testa A, Di GC et al. (1995) Vinorelbine plus cisplatin in recurrent or previously untreated unresectable squamous cell carcinoma of the head and neck. Am J Clin Oncol 18: 293-296
17. Genet D, Cupissol D, Calais G et al. (2004) Docetaxel plus 5-fluorouracil in locally recurrent and/or metastatic squamous cell carcinoma of the head and neck: a phase II multicenter study. Am J Clin Oncol 27: 472-476
18. Hao D, Ritter MA, Oliver T, Browman GP (2006) Platinum-based concurrent chemoradiotherapy for tumors of the head and neck and the esophagus. Semin Radiat Oncol 16: 10-19
19. Haughey BH, Gates GA, Arfken CL, Harvey J (1992) Meta-analysis of second malignant tumors in head and neck cancer: the case for an endoscopic screening protocol. Ann Otol Rhinol Laryngol 101: 105-112
20. Hennemann B (2006) Palliative chemotherapy of head and neck cancer: present status and future development. Laryngorhinootologie 85: 172-178
21. Herborn CU, Unkel C, Vogt FM et al. (2005) Whole-body MRI for staging patients with head and neck squamous cell carcinoma. Acta Otolaryngol 125: 1224-1229
22. Hoegler D (1997) Radiotherapy for palliation of symptoms in incurable cancer. Curr Probl Cancer 21: 129-183
23. Jackel MC, Reck R (2006) Transoral resection of locally advanced squamous cell carcinoma of the lateral oropharynx: combination of CO2 laser microsurgery with flap reconstruction. HNO 54: 605-610
24. Jacobs C, Lyman G, Velez-Garcia E et al. (1992) A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol 10: 257-263
25. Kirkbride P, Mackillop WJ, Priestman TJ et al. (1996) The role of palliative radiotherapy for bone metastases. Can J Oncol 6 [Suppl 1]: 33-38
26. Konski A, Feigenberg S, Chow E (2005) Palliative radiation therapy. Semin Oncol 32: 156-164
27. Ledeboer QC, Van d V, De Boer MF et al. (2006) Palliative care for head and neck cancer patients in general practice. Acta Otolaryngol 126: 975-980
28. Leon X, Quer M, Diez S et al. (1999) Second neoplasm in patients with head and neck cancer. Head Neck 21: 204-210
29. Moosmann P, Egli F, Stahel RA, Jost L (2003) Weekly paclitaxel and carboplatin combination chemotherapy in patients with advanced squamous cell carcinoma of the head and neck. Onkologie 26: 568-572
30. Piccirillo JF (2000) Importance of comorbidity in head and neck cancer. Laryngoscope 110: 593-602
31. Pignon JP, Bourhis J, Domenge C, Designe L (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 355: 949-955
32. Pinto HA, Jacobs C (1991) Chemotherapy for recurrent and metastatic head and neck cancer. Hematol Oncol Clin North Am 5: 667-686
33. Ricke J, Wust P, Wieners G et al. (2005) CT-guided interstitial single-fraction brachytherapy of lung tumors: phase I results of a novel technique. Chest 127: 2237-2242
34. Saxman S, Mann B, Canfield V et al. (1998) A phase II trial of vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. Am J Clin Oncol 21: 398-400
35. Schrijvers D, Vermorken JB (2000) Role of taxoids in head and neck cancer. Oncologist 5: 199-208
36. Schwentner I, Obrist P, Thumfart W, Sprinzl G (2006) Distant metastasis of parotid gland tumors. Acta Otolaryngol 126: 340-345
37. Shah JP, Lydiatt W (1995) Treatment of cancer of the head and neck. CA Cancer J Clin 45: 352-368
38. Shaw HJ (1985) Palliation in head and neck cancer. J Laryngol Otol 99: 1131-1142
39. Simon C, Plinkert PK (2006) Transoral resection of locally advanced squamous cell carcinoma of the side wall of the oropharynx: multimodal treatment concepts in transition. HNO 54: 589-590
40. Uppelschoten JM, Wanders SL, de Jong JM (1995) Single-dose radiotherapy (6 Gy): palliation in painful bone metastases. Radiother Oncol 36: 198-202
41. Werner JA (2005) Sentinel lymphadenectomy as a staging procedure. HNO 53: 511-512
42. Wulf J, Haedinger U, Oppitz U et al. (2004) Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 60: 186-196